Some large health systems are experimenting with selling their internal capabilities — such as IT support, revenue cycle management and call center operations — to smaller hospitals as a new revenue stream. While the approach is still rare, it has the potential to help health systems monetize their expertise and infrastructure, one healthcare consultant said….
“People are not picking up their medicine; they’re not seeing the doctor,” St. John’s Community Health clinics’ CEO says
Employers are projecting a median 10% increase in healthcare costs for 2026, driven largely by high claims and specialty drug expenses, according to a recent survey. The post Why Employers Predict a 10% Increase in Healthcare Costs for 2026 appeared first on MedCity News.
This timeline provides a detailed overview of actions, including counter-actions, related to the administration’s efforts to freeze all U.S. foreign aid and dissolve the U.S. Agency for International Development (USAID).
This guide provides an overview of executive orders and other executive actions made by the Trump Administration since January 21, 2025 that directly address or affect U.S. global health efforts. This resource identifies each executive action, describes its purpose and actions taken, and outlines the implications and what happens next for each. The resource will…
As they move into adulthood, many young Americans face a unique and daunting challenge: finding their own health insurance by the time they turn 26. The lucky ones are covered through their jobs. But in an age of gig employment, more are falling off the “26 insurance cliff” and landing hard. For a project produced…
Zuckerberg San Francisco General Hospital’s Lucas Zier, M.D., saw an opportunity to use the EHR for system-wide performance improvement
Pfizer’s inclacumab did not beat a placebo in a Phase 3 test in sickle cell disease. The trial failure comes nearly a year after Pfizer voluntarily withdrew Oxbryta from the market after tests showed higher rates of complications and deaths for that sickle cell disease drug. The post Pfizer Gets Another Dose of Disappointment as…
KFF and ESPN today jointly released a first-of-its-kind, in-depth polling and reporting project that sheds new light on the health issues and other challenges facing NFL players after they leave the game.
KFF and ESPN today jointly released a first-of-its-kind, in-depth polling and reporting project that sheds new light on the health issues and other challenges facing NFL players after they leave the game. The KFF/ESPN Survey of 1988 NFL Players draws on a novel survey of 546 respondents who were among the 1,532 players from the…More